| Article Access Statistics|
| Viewed||691 |
| Printed||44 |
| Emailed||0 |
| PDF Downloaded||13 |
| Comments ||[Add] |
Click on image for details.
|Year : 2017 | Volume
| Issue : 1 | Page : 21-23
Right atrial mural thrombi: An autopsy study of an under-diagnosed complication at an unusual site
P Vaideeswar1, J Chaudhari2, N Karnik2, T Sahu1, A Gupta2
1 Department of Pathology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra, India
2 Department of Medicine, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra, India
|Date of Submission||10-May-2016|
|Date of Decision||28-Jun-2016|
|Date of Acceptance||05-Aug-2016|
|Date of Web Publication||11-Jan-2017|
Department of Pathology, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra
Source of Support: None, Conflict of Interest: None
Background: Right atrial mural thrombi (RAMT) are often seen in association with cardiac diseases or foreign bodies. Unusual locations at the flutter isthmus and the atrial appendage prompted us to evaluate our 2-year autopsy data on such thrombi. Materials and Methods: In the 2-year retrospective autopsy, the clinical and autopsy records of patients with RAMT were reviewed, with particular reference to the presence of central venous catheter (CVC), its site of insertion, its type, material and size, its duration of placement, and the drugs infused through the catheter. Results: Of the 940 autopsies performed in 2 years, RAMT was seen in 24 hearts and was related to an insertion of a CVC in 23 patients (95.8%). The risk and/or associated factors for this complication were tunneled and polyethylene catheters, Intensive Care Unit admission, infused drugs, underlying cardiac diseases, and pregnancy. A noteworthy feature was the location of the thrombi in the flutter isthmus in 16 hearts (66.7%) and atrial appendage in another six hearts. Localized endocarditis/myocarditis and pulmonary thromboembolism were observed in six and four patients, respectively.Conclusions: This autopsy study, which has a high incidence of catheter-related RAMT, does not reflect the true incidence but reiterates the importance of guided insertion of central venous and prompt recognition of thrombus formation.
Keywords: Central venous catheter, endocarditis, mural thrombus, pulmonary thromboembolism, right atrium
|How to cite this article:|
Vaideeswar P, Chaudhari J, Karnik N, Sahu T, Gupta A. Right atrial mural thrombi: An autopsy study of an under-diagnosed complication at an unusual site. J Postgrad Med 2017;63:21-3
|How to cite this URL:|
Vaideeswar P, Chaudhari J, Karnik N, Sahu T, Gupta A. Right atrial mural thrombi: An autopsy study of an under-diagnosed complication at an unusual site. J Postgrad Med [serial online] 2017 [cited 2017 Mar 24];63:21-3. Available from: http://www.jpgmonline.com/text.asp?2017/63/1/21/191008
| :: Introduction|| |
From the anatomic point of view, the atria are said to possess a body, a venous component, a vestibule, and an appendage. In the right atrium (RA), the body is virtually nonexistent. When one considers the pathophysiology and location of the right atrial mural thrombi (RAMT), two types have been described: Type A thrombi that are unattached, freely mobile lying in the vestibule (commonly referred to as "emboli-in-transit") and Type B thrombi, which are attached to the right atrial free walls or to the cavoatrial junctions (toward the venous component).  These mural thrombi are seen more in association with cardiac diseases or foreign bodies. In the recent past at autopsy, we have noted the presence of thrombi attached to the flutter isthmus (a part of the right atrial vestibule below the coronary sinus and between the Eustachian valve and tricuspid annulus) and in the atrial appendage. These unusual locations prompted us to evaluate our 2-year autopsy data on RAMT.
| :: Materials and Methods|| |
A retrospective analysis of all autopsies performed by the Department of Pathology between January 2012 and December 2013 was performed for identifying RAMT. The clinical and autopsy records were reviewed. Patient demographics, duration of admission, modes of presentation, clinical diagnosis, and investigations were noted. If patients had a history of central venous catheterization, particular attention was paid to the site of central venous catheter (CVC) insertion, the type/material/size of CVC, duration of placement, and the drugs infused through the catheter. At autopsy, the site and size of the RAMT, pathology of the right atrial wall at the site of thrombosis and other associations/complications were noted along with other cardiac and extracardiac lesions.
| :: Results|| |
Of the 940 autopsies performed in 2 years, RAMT were seen in 24 hearts (2.55%). There were 19 females and 5 males with an age range of 2-70 years (mean age 30.9 years). The brief clinicopathological features have been given in [Table 1]. The patients had been admitted for a period ranging from 7 h to 27 days with a mean of 7 days. Eleven patients (48.8%) had been admitted to Intensive Care Units (ICUs) - eight in medical, two in surgical, and one in pediatric ICUs. Among the 19 women, 12 (63.2%) were pregnant. A history of insertion of CVC was present in 23 patients (95.8%). The duration of CVC insertion ranged from 2 to 36 days (mean 6.82 days). In the adult patients, the size of the catheter was 7 Fr, and the catheter size had not been selected as per the built of the patients. The catheters were made up of polyethylene. Cephalosporins were the most common drug (12 patients) infused through the catheter, followed by metronidazole, vancomycin, and meropenem. Underlying cardiac disease was present in six patients and remained undiagnosed in two patients (cases 12 and 15). A noteworthy feature was the location of the thrombi in the flutter isthmus in 16 hearts (66.7%) seen as flaky granularity, plaques, or large space-occupying masses; four among them also showed thrombi at other sites [Figure 1]. In addition, they were present in the atrial appendage in another six hearts. Localized endocarditis/myocarditis and pulmonary thromboembolism (PTE) [Figure 2] were observed in six and four patients, respectively.
|Figure 1: Thrombus (black arrows) is seen at the flutter isthmus as (a) fine endocardial granularity; (b) plaque of flaky friable yellowish-white material and (c) large reddish-brown mass. In the last panel, there is a cylindrical tract of thrombus (white arrow) in relation to the opening of superior vena cava. ATL: Anterior tricuspid leaflet, FO: Fossa ovalis, PTL: Posterior tricuspid leaflet, RA: Right atrium, RV: Right ventricle, STL: Septal tricuspid leaflet, TV: Tricuspid valve, SVC: Superior vena cava|
Click here to view
|Figure 2: (a) Thrombus T is adherent to an inflamed endocardium E. The underlying myocardium also shows the presence of inflammatory cells (H and E, ×400). (b) There is transmural inflammation of the right atrial wall at the site of the thrombus (H and E, ×400). (c) The right lung shows subpleural wedge-shaped hemorrhagic zones of infarction in the middle and lower lobes|
Click here to view
|Table 1: Right atrial mural thrombi - clinicopathological features (n=24)|
Click here to view
| :: Discussion|| |
In this short 2-year study, we found that most of the RAMTs occurred in all probability to CVC insertion, and more than 50% of the thrombi were located at an unusual site, namely the flutter isthmus. CVC insertion is a common procedure performed particularly in ICUs to monitor central venous (CV) pressure and to guide fluid replacement therapy, especially in sepsis and septic shock.  The other uses include regular hematological or biochemical monitoring antimicrobial administration, giving hemodialysis and total parenteral nutrition. The access to the central veins is achieved in most cases through peripheral veins, namely the internal jugular or subclavian veins as was the case in all our patients. Despite the ease of insertion, the procedure is prone to problems and complications, which can be early or late. Early complications occur during the procedure or within 24 h are mechanical in nature and include inadvertent pneumothorax/hemothorax, catheter breakage, extravasation of infused fluids, nerve injury, or even cardiac tamponade.  Late complications develop after 24 h and include infections and thrombosis, which could be inter-related. 
Occurrences of thrombi in association with CVCs depend on several factors  and such thrombotic episodes occur to the extent of 2-67%, mostly in the veins of the upper extremities.  Important in the pathogenesis is an endothelial injury consequent to mechanical damage, catheter-related infections, or chemical injury produced by certain drugs and other infused fluids. Catheter characteristics in the form of size, material and type, side, sites and ease of insertion, duration of placement are additional important risk factors. Patient characteristics have also a role to play. Among the 24 patients, 50% were pregnant females. Pregnancy and the postpartum period are known prothrombotic states. Furthermore, 11 out of 24 patients (48.8%) were admitted to ICUs, and such critically ill patients are at a high risk of for deep vein thrombosis and thromboembolism.  The catheters used in our patients were nonsilicone and tunneled.
The incidence of catheter-related RAMT (CR-RAMT) is said to range from 12% to even 30% as reviewed by Burns and McLaren.  In this review  and in a review concerning hemodialysis catheters,  the thrombi were found attached to the tip of the catheter and if mural, the site of adherence had not be clearly delineated. In this study, CVCs were placed in 23 out of 24 patients (95.8%), and the thrombi were located solely at the superior cavoatrial junction (2 patients, 8.3%), in the right atrial appendage (6 patients, 25%), and over the flutter isthmus (16 patients, 66.7%). The appendage and the flutter isthmus are unusual sites, and we feel that this could be related to malposition of the tip. There have been recommendations that the catheter tip should be present at the distal portion of the superior vena cava or at its junction with RA as judged by a chest X-ray using the right tracheobronchial angle.  In these cases, it may be possible that there could have been coiling of the catheter at the flutter isthmus or at its entry into the right atrial appendage, probably related to a larger than appropriate CVC size or an over-insertion. In addition, migration rhythmic motions of the atrium or movements of the arm/patient could also be contributory. Endothelial injury by the guide-wire which is longer than the CVC is yet another possibility. Recognition of such thrombi is essential to prevent subsequent rare consequences. The thrombus can serve as a nidus for microbial colonization,  a feature seen in eight of our cases; septic foci elsewhere were already present in three patients. Another more ominous outcome was PTE which was seen in three of our patients. With CV insertion, PTE is reported to occur about 15% of patients with associated mortality in 28-30% of patients.  The fatality was seen in one (4.2%) of our patients.
CR-RAMTs are fortunately rare complications of CVCs but are unfortunately underdiagnosed and can also be potentially life-threatening. This autopsy study, which has a high incidence of CR-RAMT, does not reflect the true incidence but reiterates the importance of guided insertion of CV and prompt recognition of thrombus formation. Depending on the size of the thrombus, options of repeated screenings, anticoagulation therapy, thrombolysis, or thrombectomy are recommended to prevent further disastrous outcomes. 
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| :: References|| |
Finlayson GN. Right heart thrombi: Consider the cause. Can J Cardiol 2008;24:888.
Napalkov P, Felici DM, Chu LK, Jacobs JR, Begelman SM. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: A health care claims database analysis. BMC Cardiovasc Disord 2013;13:86.
Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-6.
Linnemann B, Lindhoff-Last E. Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters. Vasa 2012;41:319-32.
Kamphuisen PW, Lee AY. Catheter-related thrombosis: Lifeline or a pain in the neck? Hematology Am Soc Hematol Educ Program 2012;2012:638-44.
Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al.
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793-800.
Burns KE, McLaren A. Catheter-related right atrial thrombus and pulmonary embolism: A case report and systematic review of the literature. Can Respir J 2009;16:163-5.
Stavroulopoulos A, Aresti V, Zounis C. Right atrial thrombi complicating haemodialysis catheters. A meta-analysis of reported cases and a proposal of a management algorithm. Nephrol Dial Transplant 2012;27:2936-44.
Vesely TM. Central venous catheter tip position: A continuing controversy. J Vasc Interv Radiol 2003;14:527-34.
Arnold IR, Brack MJ, Verma PK, McCance A. Infected right atrial thrombi: A complication of central venous cannulation. Int J Cardiol 1994;43:101-4.
Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, et al.
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009;374:159-69.
[Figure 1], [Figure 2]